Clustering data with hclust algorithm for (Study ST000196)

(Analysis AN000298)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18F19F20F21F22F23F24F25F26
Taurodeoxycholic acidME6978530.040.220.660.0110.001.900.000.015.480.550.000.000.000.150.000.000.000.000.180.030.010.000.211.480.890.81
Glycolithocholic acidME6978430.550.880.811.284.311.200.210.261.182.960.200.200.480.830.220.330.490.161.610.840.540.271.720.341.630.82
Ursodeoxycholic acidME6978560.790.480.870.478.092.790.000.001.412.470.010.000.000.170.120.131.430.070.510.020.130.010.810.652.050.52
Isolithocholic acidME6978470.090.181.120.737.021.680.040.080.961.440.200.090.720.830.140.170.470.142.510.420.411.280.620.611.100.90
Lithocholic acidME6978480.270.142.010.597.551.790.020.031.462.180.070.021.010.620.110.090.180.031.281.500.171.300.610.401.440.85
Deoxycholic acidME6978370.480.372.050.487.961.440.000.001.311.760.000.000.030.440.040.000.020.002.350.020.180.000.660.613.410.83
Glycodeoxycholic acidME6978400.380.401.340.286.711.220.010.021.831.220.020.000.030.210.030.010.010.020.720.050.090.060.421.872.330.70
Taurolithocolic acidME6978550.980.212.300.251.971.590.090.833.090.310.170.160.210.550.050.340.100.090.311.840.190.880.430.786.140.66
Glychocholic acidME6978381.990.400.890.181.861.660.070.221.140.630.030.020.070.300.200.054.120.060.810.260.130.012.623.502.070.61
Glycoursodeoxycholic acidME6978441.160.360.740.182.010.650.610.111.050.810.190.180.180.170.210.076.820.130.690.340.110.091.312.771.630.65
g-Muricholic acid (hyocholic acid)ME6978451.141.531.433.790.351.290.010.002.480.260.010.000.000.550.580.092.750.220.800.040.050.031.013.533.110.58
Chenodeoxycholic acidME6978360.931.202.170.980.542.010.030.092.120.250.040.020.010.250.140.351.050.450.960.340.470.131.602.234.312.39
?a-Muricholic acidME6978331.791.032.092.331.391.630.000.021.360.660.010.000.000.330.140.292.500.181.820.180.820.052.631.312.651.46
b-Muricholic acidME6978341.811.191.881.560.721.510.000.012.120.850.010.010.000.430.280.572.590.431.650.130.700.032.461.692.281.25
Cholic acidME6978351.500.961.891.360.971.890.150.071.730.730.190.020.030.310.290.732.240.611.620.360.570.082.291.602.331.02
Hyodeoxycholic acidME6978461.241.661.703.111.532.190.010.011.490.960.010.000.010.560.160.150.750.121.970.051.660.091.531.792.432.32
w-Muricholic acidME6978571.771.081.222.571.742.270.010.011.881.470.010.010.010.880.480.291.040.222.600.011.570.071.901.161.941.41
Taurochenodeoxycholic acidME6978520.040.481.130.025.202.551.240.493.150.281.260.120.380.430.010.260.110.820.160.330.010.030.402.370.911.13
3a,7a,12a-trihydroxycholestanoic acidME6978540.030.730.210.621.041.961.600.301.340.761.690.631.492.600.110.631.941.690.060.570.340.180.131.180.642.10
Glycohyocholic acidME6978411.031.340.560.971.250.932.720.400.360.281.321.240.570.390.120.721.400.650.860.750.550.191.072.542.000.73
Tauro-alpha-muricholic acidME6978490.460.891.321.402.101.781.060.500.960.491.980.170.700.540.080.352.022.320.480.500.700.070.741.430.831.30
Taurocholic acidME6978510.390.570.570.123.751.531.350.721.371.021.480.780.880.800.070.780.802.130.300.750.080.120.820.901.301.01
Tauro-beta-muricholic acidME6978500.441.140.970.813.061.421.030.531.170.710.920.610.540.600.130.811.731.070.550.700.350.130.971.381.791.14
TAUROHYODEOXYCHOLIC ACIDME6978580.201.011.190.253.951.900.510.580.930.621.040.420.610.400.040.551.861.220.650.630.120.090.661.481.701.38
Glycochenodeoxycholic acidME6978390.990.850.880.593.131.820.750.561.340.850.530.370.950.620.180.261.030.260.650.820.280.170.972.801.531.26
Glycohyodeoxycholic acidME6978421.041.010.840.373.051.121.930.401.440.430.910.521.010.450.080.331.250.360.800.990.360.090.781.751.961.37

Factors:

F1Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated
F2Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated
F3Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated
F4Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated
F5Recovery:na | Gender:female | Treatment:No antibiotics
F6Recovery:na | Gender:male | Treatment:No antibiotics
F7Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated
F8Recovery:no recovery | Gender:female | Treatment:IP clindamycin
F9Recovery:no recovery | Gender:female | Treatment:Kanamycin treated
F10Recovery:no recovery | Gender:female | Treatment:Metronidazole treated
F11Recovery:no recovery | Gender:female | Treatment:Vancomycin treated
F12Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated
F13Recovery:no recovery | Gender:male | Treatment:IP clindamycin
F14Recovery:no recovery | Gender:male | Treatment:Kanamycin treated
F15Recovery:no recovery | Gender:male | Treatment:Metronidazole treated
F16Recovery:no recovery | Gender:male | Treatment:Vancomycin treated
F17Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated
F18Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated
F19Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated
F20Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin
F21Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated
F22Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin
F23Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated
F24Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated
F25Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated
F26Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated
Data matrix
  logo